InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Piskel Kyle, Responsable Comptable Principal. Insider active across 1 company, notably Adaptive Biotechnologies Corp. Aggregated, 22 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €3m. Activity tracked since 15 November 2021. The latest transaction was disclosed on 11 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Piskel Kyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
18,672 股@ US$13.175.1% 占其流量Common StockSEC:0001780662-26-000006:0
61,875 股0Common StockSEC:0001780662-26-000004:0
2,145 股@ US$12.140.5% 占其流量Common StockSEC:0001780662-26-000002:0
4,290 股@ US$12.141.1% 占其流量Common StockSEC:0001780662-26-000001:0
11,980 股@ US$6.551.8% 占其流量Common StockSEC:0001780662-25-000003:0
3,750 股@ US$7.800.7% 占其流量Common StockSEC:0001780662-25-000003:1
94,384 股@ US$12.1425.6% 占其流量Common StockSEC:0001780662-25-000003:2
162,820 股@ US$19.5070.8% 占其流量Common StockSEC:0001780662-25-000003:3
238 股@ US$14.050.1% 占其流量Common StockSEC:0001780662-25-000002:0
1,929 股@ US$8.890.4% 占其流量Common StockSEC:0001062993-25-009904:0
7,815 股0Common StockSEC:0001062993-25-009837:0
2,500 股@ US$6.320.4% 占其流量Common StockSEC:0001062993-25-005645:0
125,000 股0Common StockSEC:0001062993-25-004813:0
248 股@ US$4.980.0% 占其流量Common StockSEC:0001062993-24-019373:0
31,260 股0Common StockSEC:0001062993-24-010709:0
43,740 股0Common StockSEC:0001062993-24-005768:0
259 股@ US$4.130.0% 占其流量Common StockSEC:0001062993-23-021224:0
43,735 股0Common StockSEC:0001062993-23-006330:0
307 股@ US$8.870.1% 占其流量Common StockSEC:0001209191-22-057531:0
959 股@ US$8.870.2% 占其流量Common StockSEC:0001209191-22-057432:0
41,186 股0Common StockSEC:0001209191-22-017396:0
3,837 股0Common StockSEC:0001209191-21-065312:0
22 条申报中的 22 条
About Piskel Kyle
PISKEL KYLE is Responsable Comptable Principal and Chief Financial Officer at Adaptive Biotechnologies Corp, listed on XNAS. He has 22 filings in total, and across the sampled recent filings the modal transaction nature is sell, with EUR 0 of buys and EUR 2980080 of sells between 2021-11-17 and 2026-03-13.
